The Europe Medical Holography Market was worth USD 112.06 million in 2018 and estimated to be growing at a CAGR of 30.9%, to reach USD 430.66 million by 2023. Medical Holography helps medical professionals by providing three dimensional view of the interior organs of a patient. This helps doctors in assessing the organs of a body on a desktop monitor, preventing the task of cutting through the body. By using this technology, doctors can view, manipulate and dissect internal organs, which are recreated above a desktop monitor. The extremely high growth rate in the market can be attributed to its efficacy in the medical field and has a high potential since it’s an emerging field.
Medical professionals these days construct a three dimensional model in their mind from a set of two dimensional images of internal organs so that a patient’s health status can be assessed. A significant amount of effort needs to be invested to imagine the three dimensional structure, which can be avoided with this technology. It also assists them in getting a three dimensional view of abnormal structures like the mess of ribcages and broken bones of someone injured in a road accident. Heart ailments in very young patients can be treated with ease and precision, since structures like congenital abnormalities, narrowings and aneurisms are hard to imagine. Technologies for virtual colonoscopy are being developed which is an alternative to the uncomfortable method of inserting a colonoscope inside the body.
The driving factors of Europe Medical Holography market are growth in the applications of holography in medical field, emergence of holography as a useful technology in representing abnormal 3D structures and rising adoption of holography in medical and biomedical research. The restraints of this market are high price of computation of holographs & equipment and some machines rendering imprecise holographs.
The Europe Medical Holography market is segmented on the basis of product type into holographic displays, holographic prints, holography microscopes, holoscopes and holography software. By application, the market is segmented into medical imaging, biomedical research and medical education. On the basis of end users, the market is categorised into research laboratories, hospitals and clinics, academic medical centres and pharmaceutical and biotechnology companies.
The Europe Medical Holography market is divided based on geography into United Kingdom, France, Germany, Italy and Spain. Europe is expected to be the second largest market in the world, followed by North America. Factors like efficacy of holographic devices in the medical field along with rising investment for innovation is expected to drive the market growth in the region.
Some of the major players in the market include EchoPixel, Inc. (U.S.), Lyncee Tec (Switzerland), Eon Reality (U.S.), Holografika Kft. (Hungary), Realview Imaging Ltd. (Israel), Mach7 Technologies Pte. Ltd. (Australia), Ovizio Imaging systems (Belgium), Holoxica Ltd. (U.K.), zSpace, Inc. (U.S.), Zebra Imaging (U.S.), and NanoLive SA (Switzerland).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product Type
5.1.1 Holographic Displays
5.1.2 Holographic Prints
5.1.3 Holography Microscopes
5.1.4 Holoscopes
5.1.5 Holography Software
5.1.6 Y-o-Y Growth Analysis, By Product Type
5.1.7 Market Attractiveness Analysis, By Product Type
5.1.8 Market Share Analysis, By Product Type
5.2 End Users
5.2.1 Research Laboratories
5.2.2 Hospitals and Clinics
5.2.3 Academic Medical Centres
5.2.4 Pharmaceutical and Biotechnology Companies
5.2.5 Y-o-Y Growth Analysis, By End Users
5.2.6 Market Attractiveness Analysis, By End Users
5.2.7 Market Share Analysis, By End Users
5.3 Application
5.3.1 Medical Imaging
5.3.2 Biomedical Research
5.3.3 Medical Education
5.3.4 Other Applications
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Product Type
6.1.3.2 By End Users
6.1.3.3 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Product Type
6.1.4.2 By End Users
6.1.4.3 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Product Type
6.1.5.2 By End Users
6.1.5.3 By Application
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 EchoPixel, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Lyncee Tec
8.3 Eon Reality
8.4 Holografika Kft.
8.5 Realview Imaging Ltd.
8.6 Mach7 Technologies Pte. Ltd.
8.7 Ovizio Imaging systems
8.8 Holoxica Ltd.
8.9 zSpace, Inc.
8.10 Zebra Imaging
8.11 NanoLive SA
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
